Search results
CRYOcheck Prekallikrein Deficient Plasma, frozen
Deficient substrate for clot-based prekallikrein assays.
CRYOcheck Protein C Clot-based Test (frozen)
Clot-based assay for the quantitative determination of protein C activity in citrated human plasma.
Diluent C&S for CRYOcheck Clot C Assay
Optimized for CRYOcheck TM Clot C und S tests.
DOAC-Remove™20
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™50
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™250
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DP-Filter®
DP-Filter®is effective in filtering direct oral anticoagulants (DOACs), which interfere in various coagulometric coagulation tests, from citrated plasma providing anticoagulant-free plasma that can be used for testing. For research use only.
ELISA Dilution buffer, with albumin, pH 7.50
For immuno-enzymatic assays.
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Factor II (Fragment 1), Human